Skip to main content
. 2021 Jan 13;13(1):93. doi: 10.3390/pharmaceutics13010093

Figure 1.

Figure 1

Solid lipid particle (SLP) characterization. (a) Composition of the SLPs. (b) Hydrodynamic particle size (right) and ζ potential (left) of the control SLPs (yellow) and SLPs loaded with doxorubicin (DOX) (red). (c) Representative TEM micrographs of SLPs. The Fe3O4 nanoparticles are visible as dark structures inside the composite (inset).